• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铝冶炼工人的膀胱癌筛查

Bladder cancer screening in aluminum smelter workers.

作者信息

Taiwo Oyebode A, Slade Martin D, Cantley Linda F, Tessier-Sherman Baylah, Galusha Deron, Kirsche Sharon R, Donoghue A Michael, Cullen Mark R

机构信息

From the Yale Occupational and Environmental Medicine Program (Dr Taiwo, Ms Slade, Ms Cantley, Ms Tessier-Sherman, Mr Galusha, and Ms Kirsche), Yale University School of Medicine, New Haven, Conn; Alcoa, Inc (Dr Donoghue), Western Australia; and General Medical Disciplines (Dr Cullen), Stanford University School of Medicine, Calif.

出版信息

J Occup Environ Med. 2015 Apr;57(4):421-7. doi: 10.1097/JOM.0000000000000377.

DOI:10.1097/JOM.0000000000000377
PMID:25525927
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4374722/
Abstract

OBJECTIVE

To present results of a bladder cancer screening program conducted in 18 aluminum smelters in the United States from January 2000 to December 2010.

METHODS

Data were collected on a cohort of workers with a history of working in coal tar pitch volatile exposed areas including urine analysis for conventional cytology and ImmunoCyt/uCyt+ assay.

RESULTS

ImmunoCyt/uCyt+ and cytology in combination showed a sensitivity of 62.30%, a specificity of 92.60%, a negative predictive value of 99.90%, and a positive predictive value of 2.96%. Fourteen cases of bladder cancer were detected, and the standardized incidence ratio of bladder cancer was 1.18 (95% confidence interval, 0.65 to 1.99). Individuals who tested positive on either test who were later determined to be cancer free had undergone expensive and invasive tests.

CONCLUSIONS

Evidence to support continued surveillance of this cohort has not been demonstrated.

摘要

目的

呈现2000年1月至2010年12月在美国18家铝冶炼厂开展的膀胱癌筛查项目的结果。

方法

收集了一组有在煤焦油沥青挥发物暴露区域工作史的工人的数据,包括用于传统细胞学检查的尿液分析以及免疫细胞/uCyt+检测。

结果

免疫细胞/uCyt+与细胞学检查相结合显示,灵敏度为62.30%,特异度为92.60%,阴性预测值为99.90%,阳性预测值为2.96%。检测出14例膀胱癌病例,膀胱癌的标准化发病比为1.18(95%置信区间,0.65至1.99)。两种检测中任一种检测呈阳性但后来被确定无癌症的个体都接受了昂贵且有创的检查。

结论

尚未证实有证据支持对该队列继续进行监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47de/4374722/c56f2043a0b1/joem-57-421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47de/4374722/b743d8744c0b/joem-57-421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47de/4374722/c56f2043a0b1/joem-57-421-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47de/4374722/b743d8744c0b/joem-57-421-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47de/4374722/c56f2043a0b1/joem-57-421-g002.jpg

相似文献

1
Bladder cancer screening in aluminum smelter workers.铝冶炼工人的膀胱癌筛查
J Occup Environ Med. 2015 Apr;57(4):421-7. doi: 10.1097/JOM.0000000000000377.
2
The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.免疫细胞/u细胞+检测在膀胱原位癌检测及随访中的价值。
Anticancer Res. 2005 Sep-Oct;25(5):3641-4.
3
Mortality and cancer morbidity in workers from an aluminium smelter with prebaked carbon anodes--Part II: Cancer morbidity.使用预焙碳阳极的铝冶炼厂工人的死亡率和癌症发病率——第二部分:癌症发病率
Occup Environ Med. 1995 Apr;52(4):250-4. doi: 10.1136/oem.52.4.250.
4
uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.uCyt+/ImmunoCyt 与细胞学在尿路上皮癌检测中的应用:7422 例分析更新。
Cancer Cytopathol. 2013 Jul;121(7):392-7. doi: 10.1002/cncy.21287. Epub 2013 Mar 12.
5
Bladder cancer screening among primary aluminum production workers in Quebec.魁北克初级铝生产工人的膀胱癌筛查。
J Occup Med. 1990 Sep;32(9):869-72. doi: 10.1097/00043764-199009000-00021.
6
Investigation of the presence of amino and nitro polycyclic aromatic hydrocarbons in a Söderberg primary aluminum smelter.索德伯格法原铝冶炼厂中氨基和硝基多环芳烃存在情况的调查。
AIHA J (Fairfax, Va). 2002 Nov-Dec;63(6):721-5. doi: 10.1080/15428110208984761.
7
Combinations of urine-based tumour markers in bladder cancer surveillance.基于尿液的肿瘤标志物组合在膀胱癌监测中的应用
Scand J Urol Nephrol. 2009;43(6):461-6. doi: 10.3109/00365590903296837.
8
Early results of urothelial carcinoma screening in a risk population of coke workers: urothelial carcinoma among coke workers.焦炉作业工人风险人群中的尿路上皮癌筛查的早期结果:焦炉工人中的尿路上皮癌。
Biomed Environ Sci. 2010 Aug;23(4):300-4. doi: 10.1016/S0895-3988(10)60067-0.
9
uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.尿细胞阳性(uCyt+)检测:用于低风险尿路上皮癌患者微创随访的膀胱镜检查替代方法。
Urology. 2006 May;67(5):950-4. doi: 10.1016/j.urology.2005.11.057.
10
Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.免疫细胞检测和HA-HAase尿液检测用于膀胱癌检测:并列比较
Eur Urol. 2004 Oct;46(4):466-71. doi: 10.1016/j.eururo.2004.06.006.

引用本文的文献

1
Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival.尿路上皮膀胱癌的偶然诊断:与总生存期的关联
Cancers (Basel). 2023 Jan 21;15(3):668. doi: 10.3390/cancers15030668.
2
Cancer and noncancer mortality among aluminum smelting workers in Badin, North Carolina.北卡罗来纳州巴丁地区铝冶炼工人的癌症和非癌症死亡率。
Am J Ind Med. 2020 Sep;63(9):755-765. doi: 10.1002/ajim.23150. Epub 2020 Jul 10.
3
Cohort Profile: The American Manufacturing Cohort (AMC) study.队列简介:美国制造业队列(AMC)研究。

本文引用的文献

1
The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.血尿在曾有芳香胺职业暴露的男性膀胱癌筛查中的作用。
BJU Int. 2011 Aug;108(4):546-52. doi: 10.1111/j.1464-410X.2010.09971.x. Epub 2011 Jan 11.
2
Early results of urothelial carcinoma screening in a risk population of coke workers: urothelial carcinoma among coke workers.焦炉作业工人风险人群中的尿路上皮癌筛查的早期结果:焦炉工人中的尿路上皮癌。
Biomed Environ Sci. 2010 Aug;23(4):300-4. doi: 10.1016/S0895-3988(10)60067-0.
3
Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force.
Int J Epidemiol. 2019 Oct 1;48(5):1412-1422j. doi: 10.1093/ije/dyz059.
筛查成年人膀胱癌:美国预防服务工作组的证据回顾。
Ann Intern Med. 2010 Oct 5;153(7):461-8. doi: 10.7326/0003-4819-153-7-201010050-00009.
4
Urine cytology and adjunct markers for detection and surveillance of bladder cancer.用于膀胱癌检测和监测的尿液细胞学及辅助标志物。
Am J Transl Res. 2010 Jul 25;2(4):412-40.
5
Bladder carcinoma: MDCT cystography and virtual cystoscopy.
Abdom Imaging. 2010 Jun;35(3):257-64. doi: 10.1007/s00261-009-9530-y. Epub 2009 May 27.
6
Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker.使用即时检测尿液蛋白肿瘤标志物对高危无症状人群进行膀胱癌筛查。
J Urol. 2009 Jul;182(1):52-7; discussion 58. doi: 10.1016/j.juro.2009.02.142. Epub 2009 May 17.
7
Relationship between cardiopulmonary mortality and cancer risk and quantitative exposure to polycyclic aromatic hydrocarbons, fluorides, and dust in two prebake aluminum smelters.两家预焙铝冶炼厂中心血管和肺部疾病死亡率与癌症风险以及多环芳烃、氟化物和粉尘定量暴露之间的关系
Cancer Causes Control. 2009 Aug;20(6):905-16. doi: 10.1007/s10552-009-9329-8. Epub 2009 Mar 18.
8
Mortality and cancer incidence in workers in two Australian prebake aluminium smelters.澳大利亚两家预焙铝冶炼厂工人的死亡率和癌症发病率
Occup Environ Med. 2009 Jul;66(7):464-70. doi: 10.1136/oem.2008.040964. Epub 2009 Feb 12.
9
Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.
Scand J Urol Nephrol Suppl. 2008 Sep(218):191-212. doi: 10.1080/03008880802284936.
10
Biomarkers for detection and surveillance of bladder cancer.用于膀胱癌检测和监测的生物标志物。
Can Urol Assoc J. 2008 Jun;2(3):212-21. doi: 10.5489/cuaj.600.